Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05925816 · ClinicalTrials.gov registry record · NA

Guided Feedback in an Online Game Impacts Decision Making

A NA study of Depressive Symptoms, sponsored by Bard College.

Completed
Registry status
NA
Development phase
350
Enrollment target
1
Study location

NCT05925816 is a NA study of Depressive Symptoms that has completed, run by Bard College. The registered enrollment target is 350 participants, above the 256-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (37% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05925816, a NA study of Depressive Symptoms, has completed, sponsored by Bard College.

COMPLETED
Registry status
NA
Development phase
350 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to evaluate the use of a text-based game as a way to understand decision making and knowledge related to anxiety, stress, and mood states like depression or loneliness. The investigators are interested in identifying whether participants who are given feedback before and during the game will report changes in behavior or depressive symptoms over the course of a one-week period. This is a follow-up to the published study from the researchers.

Conditions Studied

Interventions

  • BEHAVIORAL Video
  • BEHAVIORAL Active game
  • BEHAVIORAL Neutral game

Study Locations (1)

New York

  • Bard College - Annandale-on-Hudson

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2022-02-02
Est. Completion 2022-05-04
Phase NA

Sponsor

Bard College

2 total trials

What the Registry Record Tells You About NCT05925816

The ClinicalTrials.gov registry entry for NCT05925816 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 256-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (37% higher). The listed sponsor is Bard College, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Depressive Symptoms appearing as the primary indexed condition, and to 3 interventions - of which Video is the first listed.

NCT05925816 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05925816 about?

NCT05925816 is a clinical study titled "Guided Feedback in an Online Game Impacts Decision Making". The purpose of the study is to evaluate the use of a text-based game as a way to understand decision making and knowledge related to anxiety, stress, and mood states like depression or loneliness. The investigators are interested in identifying whether participants who are given feedback before and ...

What is the current status of trial NCT05925816?

This trial is currently completed. It is a NA study. The enrollment target is 350 participants. The study started on 2022-02-02. Estimated completion is 2022-05-04.

What conditions does trial NCT05925816 study?

This clinical trial studies the following conditions: Depressive Symptoms.

What interventions are being tested in trial NCT05925816?

The interventions under investigation include: Video (BEHAVIORAL), Active game (BEHAVIORAL), Neutral game (BEHAVIORAL).

Who is sponsoring clinical trial NCT05925816?

This trial is sponsored by Bard College, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05925816 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depressive Symptoms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.